The case for adding X-linked agammaglobulinemia to newborn screening
LymphoSign Journal · 2015
DOI: 10.14785/lpsn-2014-0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift LymphoSign Journal, 2015. Verfasst von Chaim M. Roifman. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
X-linked agammaglobulinemia typically presents in infancy or childhood with microbial infections as a consequence of low to absent mature B cells and pan-hypogammaglobulinemia, caused by mutations in BTK. However, atypical presentation in some cases may delay the diagnosis as well as the implementation of appropriate replacement therapy.
Zitieren
APA
Roifman, C. M. (2015). The case for adding X-linked agammaglobulinemia to newborn screening. LymphoSign Journal. https://doi.org/10.14785/lpsn-2014-0010
Vancouver
Roifman CM. The case for adding X-linked agammaglobulinemia to newborn screening. LymphoSign Journal. 2015. doi:10.14785/lpsn-2014-0010
BibTeX
@article{Roifman2015,
author = {Roifman, Chaim M.},
title = {The case for adding X-linked agammaglobulinemia to newborn screening},
journal = {LymphoSign Journal},
year = {2015},
doi = {10.14785/lpsn-2014-0010}
}
EUVIMED